The Food and Drug Administration authorized on Friday both the Moderna and Pfizer-BioNTech coronavirus vaccines for the nation’s youngest children, a relief to many parents anxious to protect their children 18 months after shots were first made available to adults. Regulators followed the recommendation of independent experts on an advisory panel, who voted unanimously on…
WASHINGTON — The only Americans still not eligible for coronavirus vaccines — babies, toddlers and preschoolers — appear on the verge of finally getting cleared to receive them after an advisory panel to the Food and Drug Administration voted unanimously on Wednesday to recommend the Pfizer and Moderna vaccines for the group. The F.D.A. appears…
Moderna released results on Wednesday on an updated coronavirus vaccine targeting the Omicron variant, calling it “our lead candidate” to serve as a booster shot in the fall. The firm’s researchers tested a booster dose combining the original vaccine with one targeted specifically against Omicron, the variant that became dominant last winter. They found that…